These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12711577)

  • 1. Are you missing your "must-use" medications?
    Harv Heart Lett; 2003 Apr; 13(8):6-7. PubMed ID: 12711577
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute and chronic management of atrial fibrillation in patients with late-stage CKD.
    Aronow WS
    Am J Kidney Dis; 2009 Apr; 53(4):701-10. PubMed ID: 19324248
    [No Abstract]   [Full Text] [Related]  

  • 3. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?
    Ho SF; O'Mahony MS; Steward JA; Burr ML; Buchalter M
    Age Ageing; 2004 Sep; 33(5):488-92. PubMed ID: 15271642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Betablockers and the treatment of chronic heart failure].
    Martínez Martínez JA
    Medicina (B Aires); 1999; 59(6):793-7. PubMed ID: 10752230
    [No Abstract]   [Full Text] [Related]  

  • 5. Protocol Underemphasizes beta-blockers.
    Chase SL
    J Am Pharm Assoc (Wash); 2001; 41(6):793-4. PubMed ID: 11765101
    [No Abstract]   [Full Text] [Related]  

  • 6. The renin-angiotensin-aldosterone system in atrial fibrillation: a new therapeutic target?
    Freestone B; Beevers DG; Lip GY
    J Hum Hypertens; 2004 Jul; 18(7):461-5. PubMed ID: 14973520
    [No Abstract]   [Full Text] [Related]  

  • 7. Guidelines for choosing drugs in chronic heart failure.
    Tabrizchi R
    Vasc Health Risk Manag; 2005; 1(3):171-2. PubMed ID: 17319102
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-antiarrhythmic drugs in atrial fibrillation: a review of non-antiarrhythmic agents in prevention of atrial fibrillation.
    Lally JA; Gnall EM; Seltzer J; Kowey PR
    J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1222-8. PubMed ID: 17553070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment for heart failure: good news and bad.
    Assomull R; Elliott PM
    Hosp Med; 2005 Feb; 66(2):102-5. PubMed ID: 15739707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular basis for therapeutic choices in heart failure.
    Opie LH
    Circulation; 2004 Oct; 110(17):2559-61. PubMed ID: 15505109
    [No Abstract]   [Full Text] [Related]  

  • 11. Conclusions on the management of heart failure.
    Swedberg K
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S34-6. PubMed ID: 15526241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New strategies in the treatment of atrial fibrillation].
    Tamargo Menéndez J
    An R Acad Nac Med (Madr); 2007; 124(2):305-16; discussion 316-8. PubMed ID: 18069598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta-blockers in the treatment of systolic dysfunction after myocardial infarction. Closing the circle?].
    Martínez Martínez JA
    Medicina (B Aires); 2001; 61(3):376-7. PubMed ID: 11474890
    [No Abstract]   [Full Text] [Related]  

  • 14. Atrial fibrillation and heart failure: natural history and pharmacological treatment.
    Savelieva I; John Camm A
    Europace; 2004 Sep; 5 Suppl 1():S5-19. PubMed ID: 15450275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality indicators for the management of heart failure in vulnerable elders.
    Fonarow GC
    Ann Intern Med; 2001 Oct; 135(8 Pt 2):694-702. PubMed ID: 11601952
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimal pharmacologic and non-pharmacologic management of cardiac transplant candidates: approaches to be considered prior to transplant evaluation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006.
    Jessup M; Banner N; Brozena S; Campana C; Costard-Jäckle A; Dengler T; Hunt S; Metra M; Rahmel A; Renlund D; Ross H; Warner Stevenson L
    J Heart Lung Transplant; 2006 Sep; 25(9):1003-23. PubMed ID: 16962463
    [No Abstract]   [Full Text] [Related]  

  • 17. Invited commentary.
    Thomas SP
    Ann Thorac Surg; 2009 Sep; 88(3):807-8. PubMed ID: 19699902
    [No Abstract]   [Full Text] [Related]  

  • 18. When should we discontinue antiarrhythmic therapy for atrial fibrillation after coronary artery bypass grafting? A prospective randomized study.
    Izhar U; Ad N; Rudis E; Milgalter E; Korach A; Viola N; Levi E; Asraff G; Merin G; Elami A
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):401-6. PubMed ID: 15678052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will warfarin soon be passé? New approaches to stroke prevention in atrial fibrillation.
    Hammwöhner M; Goette A
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):18-27. PubMed ID: 18594479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessing guidelines for heart failure.
    Drexler H; Wollert KC
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S28-33. PubMed ID: 15526240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.